🔔 Earnings Alert
Akums Drugs reports a 16% YoY rise in adjusted net profit to ₹66.7 crore, despite an 11.9% decline in revenue due to fluctuating API prices.
Day's High
52 Week's High
Returns % | |
1 Month Return | -15.16 % |
3 Month Return | -18.89 % |
1 Year Return | -10 % |
Market Stats | |
Previous Close | ₹716.60 |
Open | ₹702.00 |
Volume | 9.81L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹11,278.85Cr |
P/E Ratio | 37.26 |
PEG Ratio | 1.24 |
Market Cap | ₹11,278.85 Cr |
P/B Ratio | 0 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 91.28 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹11,278.85 Cr | -2% | 0.00 | ₹97 Cr | ₹4,178 Cr | |
NA | ₹38.86 Cr | 18.02% | 0.54 | NA | NA | |
BUY | ₹14,604.82 Cr | -0.61% | 0.52 | ₹602 Cr | ₹2,851 Cr | |
NA | ₹115.82 Cr | 55.83% | 0.55 | NA | NA | |
NA | ₹0.00 Cr | 7.67% | -5.26 | NA | NA |
Organisation | Akums Drugs & Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Today's Timeline - 12 Nov
05:30 AM
-Akums Drugs reports a 16% YoY rise in adjusted net profit to ₹66.7 crore, despite an 11.9% revenue decline.
09:43 AM
-Shares of Akums Drugs drop over 4% to a 52-week low following Q2 FY25 results, despite significant profit growth.
12:21 PM
-Akums Drugs shares tank 10%, falling below issue price after weak Q2 earnings report.
Today's Timeline - 12 Nov
02:35 PM
-Akums Drugs expects flat revenues for 2024-25, with a focus on maintaining margins in the CDMO business.
Key events for Akums Drugs & Pharmaceuticals Ltd
Akums Drugs & Pharmaceuticals reported a 16% rise in net profit despite an 11.9% revenue decline. Shares fell significantly following weak Q2 results, reaching a 52-week low. The company anticipates flat revenues for 2024-25 while focusing on maintaining margins in its CDMO business.
Akums Drugs Shares Fall Despite Strong Profit Growth - 11 Nov, 2024
Akums Drugs' stock fell over 4% following mixed Q2 FY25 results. Revenue dropped 12.5% YoY to ₹1,033.09 crore, but net profit surged 103.8% YoY to ₹66.65 crore.
Akums Drugs Shares Surge on Triple Hair Agreement - 16 Oct, 2024
Akums Drugs & Pharmaceuticals Ltd. shares surged over 5% after announcing a license and distribution agreement with Canada’s Triple Hair Inc. for exclusive rights in India.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
Mutual Funds have increased holdings from 3.07% to 5.18% in Sep 2024 quarter
FII Holding Up
Foreign Institutions have increased holdings from 5.32% to 7.34% in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 75.26% of holdings in Sep 2024 quarter
Price Dip
In the last 7 days, AKUMS stock has moved down by -13.9%
Retail Holding Down
Retail Investor have decreased holdings from 9.09% to 7.15% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 75.26% | 0.00 | |
Foreign Institutions | 7.34% | 37.95 | |
Mutual Funds | 5.18% | 68.40 | |
Retail Investors | 7.15% | ||
Others | 5.07% |
Akums Drugs & Pharmaceuticals Ltd in the last 5 years
Lowest (37.26x)
November 11, 2024
Today (37.26x)
November 11, 2024
Industry (56.74x)
November 11, 2024
Highest (65.57x)
August 19, 2024
Akums Drugs & Pharmaceuticals Ltd’s net profit jumped 105% since last year same period to ₹65.21Cr in the Q2 2024-2025. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated 8.38% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Akums Drugs & Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Akums Drugs & Pharmaceuticals Ltd (AKUMS) share price today is ₹644.95
Akums Drugs & Pharmaceuticals Ltd is listed on NSE
Akums Drugs & Pharmaceuticals Ltd is listed on BSE
PE Ratio of Akums Drugs & Pharmaceuticals Ltd is 37.26
PE ratio = Akums Drugs & Pharmaceuticals Ltd Market price per share / Akums Drugs & Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Akums Drugs & Pharmaceuticals Ltd(AKUMS) is 9.81L.
Today’s market capitalisation of Akums Drugs & Pharmaceuticals Ltd(AKUMS) is ₹11278.85Cr.
Akums Drugs & Pharmaceuticals Ltd(AKUMS | Price |
---|---|
52 Week High | ₹1175.9 |
52 Week Low | ₹644.95 |
Akums Drugs & Pharmaceuticals Ltd(AKUMS) share price is ₹644.95. It is down -45.15% from its 52 Week High price of ₹1175.9
Akums Drugs & Pharmaceuticals Ltd(AKUMS) share price is ₹644.95. It is up 0.00% from its 52 Week Low price of ₹644.95
Akums Drugs & Pharmaceuticals Ltd(AKUMS | Returns |
---|---|
1 Day Returns | -71.65% |
1 Month Returns | -15.16% |
3 Month Returns | -18.89% |
1 Year Returns | -10% |